We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01101711
Recruitment Status : Completed
First Posted : April 12, 2010
Last Update Posted : September 7, 2012
Information provided by (Responsible Party):

Study Description
Brief Summary:
Investigation of the incidence of endocrine dysfunction following subarachnoid hemorrhage (SAH), and to see if this has a relation to CNS lesions as evaluated by MRI and to common symptoms after SAH such as general exhaustion, lack of initiative, increased sleep demand and reduced quality of life.

Condition or disease
Endocrine Dysfunction Cerebral Infarctions Quality of Life

Study Design

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Endocrine Dysfunction and Quality of Life After Subarachnoid Hemorrhage
Study Start Date : November 2006
Primary Completion Date : February 2011
Study Completion Date : September 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding
U.S. FDA Resources

Groups and Cohorts

Patients with subarachnoid hemorrhage

Outcome Measures

Biospecimen Retention:   None Retained
Blood and urine samples

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients from the southern part of Sweden who have suffered subarachnoid hemorrhage and admitted to the Department of Neurosurgery in Lund

Inclusion Criteria:

  • acute aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • unable to give informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01101711

Department of Neurosurgery
Lund, Sweden
Sponsors and Collaborators
Lund University Hospital
More Information

Responsible Party: Erik Kronvall, Dr., Lund University Hospital
ClinicalTrials.gov Identifier: NCT01101711     History of Changes
Other Study ID Numbers: 65/2006
First Posted: April 12, 2010    Key Record Dates
Last Update Posted: September 7, 2012
Last Verified: September 2012

Additional relevant MeSH terms:
Subarachnoid Hemorrhage
Cerebral Infarction
Pathologic Processes
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Brain Infarction
Brain Ischemia